Renee Martin, PhD, is an Associate Professor of Biostatistics in the Department of Public Health Sciences and the Biostatistics Section Head for the Data Coordination Unit. She has extensive experience and expertise in the planning, implementation and analysis of Phase I-III clinical trials. With emphasis in stroke therapies and aneurysm repair, she serves or has served as an unblinded statistician for several NINDS-sponsored and industry-sponsored. Dr. Martin has served as the primary statistician and statistical PI for the ALISAH, LARGE, ENACT trials and the Phase I trial of N-acetylcysteine in maternal chorioamnionitis to decrease inflammation in the fetal brain and improve neurologic outcomes (CHORIO). Dr. Martin also serves as the primary statistician for the Characterization of Intracranial Atherosclerotic Stenosis using High-resolution MRI (CHIASM) Study and the CTA Spot Sign Score in Acute Cerebral Hemorrhage (SCORE-IT) Study which focus on MRI and/or brain imaging for prediction of clinical outcomes rather than therapeutic interventions, and she has participated as a statistical member of the NINDS-appointed DSMB for the ARUBA trial of arteriovenous malformation and currently serves on the Core DSMB for the NINDS NeuroNEXT projects. Dr. Martin also works collaboratively with DCU faculty/students to publish on methodological issues in clinical trials, such as covariate imbalance and adaptive randomization in clinical trial designs and statistical aspects of interim analysis.